Testosterone, Muscle, and the Women’s Research Gap

HormoneSynergy®
Preventive Longevity Medicine
HormoneSynergy® Clinic — Portland & Lake Oswego, Oregon | USA

Testosterone in Women Is Not Just a Libido Conversation

Testosterone in women is still most often discussed in relation to libido. That is part of the clinical conversation, but it is too narrow.

Women make testosterone. Women have androgen receptors. Skeletal muscle responds to sex hormones. After menopause, and especially after surgical menopause or ovarian suppression, women may experience changes in muscle mass, strength, recovery, body composition, energy, motivation, and sexual function.

Estradiol is important, but it is not the entire hormone story. When testosterone is low and the clinical picture fits, androgen status deserves to be evaluated rather than ignored.

This does not mean every woman needs testosterone. It does not mean testosterone is a sarcopenia drug. It does not justify supraphysiologic dosing, bodybuilding goals, or wellness-influencer claims. It means low testosterone in a symptomatic woman should be taken seriously.

The Current Guideline Problem

The formal guideline position on testosterone therapy in women remains conservative. The 2019 Global Consensus Position Statement concluded that the only clearly evidence-based indication for testosterone therapy in women is hypoactive sexual desire disorder, with insufficient evidence to recommend testosterone for other symptoms, clinical conditions, or disease prevention.

The Endocrine Society has also warned against diagnosing a broad “androgen deficiency syndrome” in healthy women because of limitations in testing, reference ranges, and outcome data.

Those cautions are reasonable. They should be respected. They also point to a larger problem: women have not had the same depth of outcomes-based testosterone research that men have.

In men, low testosterone with low muscle mass, low strength, low bone density, anemia, low libido, and reduced vitality is usually treated as a meaningful clinical pattern. In women, similar concerns are often attributed to aging, menopause, stress, or lifestyle without the same level of hormonal evaluation.

That difference in clinical framing reflects a research gap that still affects patient care.

Muscle Is Not Just a Male Hormone Issue

Sarcopenia is the progressive loss of muscle mass, strength, and function with aging. It is not cosmetic. It affects insulin sensitivity, fall risk, fracture risk, independence, metabolic health, and long-term resilience.

Women are especially vulnerable during the menopause transition because sex-hormone changes often occur during the same period when muscle loss, visceral fat gain, insulin resistance, sleep disruption, inflammation, and reduced training capacity may accelerate.

Estradiol has documented relevance to skeletal muscle. Research has linked estrogen signaling to satellite cell activity, inflammatory regulation, mitochondrial function, muscle quality, and inflammatory stress response. Estradiol should not be reduced to a reproductive hormone.

Testosterone also has biologic relevance. It is involved in lean mass, muscle protein metabolism, physical function, sexual function, motivation, and recovery. In men, that connection is widely accepted. In women, the same conversation is often minimized because the clinical trial literature is thinner.

Thin evidence is not the same as no biology. It means the claims have to be made carefully.

What the Evidence Supports

The strongest evidence for testosterone therapy in women is sexual desire and sexual function, especially in appropriately selected postmenopausal women with hypoactive sexual desire disorder.

There is also biologic plausibility for testosterone’s role in muscle health, particularly in women with low measured testosterone, surgical menopause, poor recovery, low strength, low libido, low motivation, or worsening body composition.

Research on menopause and sarcopenia supports the role of sex steroids in muscle aging. Estradiol appears important for muscle quality and inflammatory regulation. Testosterone decline may also contribute to changes in lean mass and strength, but the interventional evidence in women is not strong enough to make testosterone a universal sarcopenia treatment.

Testosterone should not be used as a shortcut around resistance training, protein, sleep, vitamin D, metabolic health, and inflammation control. It should also not be dismissed when the patient’s history, symptoms, labs, and body-composition pattern suggest it may be relevant.

Clinical Boundaries

Testosterone should not be described as a proven sarcopenia-prevention therapy for all women. It should not be presented as required for every woman using estradiol. Low muscle mass does not automatically mean testosterone deficiency. Testosterone therapy should not be used to chase bodybuilding outcomes, supraphysiologic levels, or influencer-driven “optimization.”

A more careful clinical position is that testosterone deserves consideration when a woman has low measured testosterone along with a pattern that fits: loss of muscle, worsening visceral fat, low strength, poor recovery, low drive, low libido, surgical menopause, or persistent symptoms despite appropriate attention to estradiol and the foundations of health.

Patient-Facing Language

At HormoneSynergy®, we do not view testosterone in women as a bodybuilding hormone or a wellness trend. We view it as one of the hormones women naturally make.

When a woman has low testosterone, low muscle mass, poor recovery, loss of strength, low libido, low motivation, or changes after surgical menopause, it makes clinical sense to evaluate androgen status instead of treating estradiol as the entire hormone story.

The strongest formal evidence for testosterone therapy in women is for sexual desire and sexual function. The evidence for muscle and sarcopenia is not as complete, but that does not mean testosterone is irrelevant. It means women have not been studied as thoroughly as they should have been.

Testosterone is not a substitute for resistance training, adequate protein, vitamin D, sleep, and metabolic health. In the right patient, with low levels and the right clinical picture, it deserves consideration.

The Practical HormoneSynergy® Position

HormoneSynergy® does not use testosterone to masculinize women, chase supraphysiologic levels, or turn hormone therapy into an anti-aging trend.

Our position is straightforward. Women make testosterone. Muscle matters. The hormone conversation should not stop at estradiol when symptoms, labs, surgical history, body composition, and clinical context suggest a broader issue.

In preventive longevity medicine, muscle is one of the strongest markers of future resilience. If we are serious about women’s healthspan, we have to take strength, body composition, hormones, and the research gap seriously.

Clinical Bottom Line

Estradiol matters. Testosterone may matter too. Exercise, protein, vitamin D, sleep, and metabolic health remain the foundation.

When a woman has low testosterone and a clinical picture that fits, dismissing testosterone because the research is incomplete may not be caution. It may be another example of the women’s health gap showing up in midlife and longevity medicine.

Frequently Asked Questions

Is testosterone only important for libido in women?

No. The strongest formal evidence for testosterone therapy in women is for hypoactive sexual desire disorder, but testosterone is also biologically relevant to muscle, bone, mood, motivation, recovery, and physical function. The research outside sexual function is less complete.

Does testosterone prevent sarcopenia in women?

Testosterone should not be described as a proven sarcopenia-prevention therapy for all women. The evidence is not that strong. Low testosterone may still be clinically relevant in some women with muscle loss, poor recovery, low strength, low libido, surgical menopause, or worsening body composition.

Is estradiol enough after menopause?

Sometimes. Estradiol is important for many aspects of women’s health, including skeletal muscle biology, inflammation, insulin sensitivity, and connective tissue. Estradiol is not always the entire hormone story. Women also make testosterone, and androgen status may matter when levels are low and symptoms fit.

Does every woman on estradiol need testosterone?

No. Testosterone therapy should be individualized. It should be based on symptoms, labs, surgical history, body composition, medication history, risk factors, and clinical judgment.

What is the women’s research gap?

The women’s research gap refers to the fact that many areas of women’s physiology, including testosterone, muscle aging, menopause, and long-term functional outcomes, have not been studied as thoroughly as they should have been. Thin evidence should not be used to make exaggerated claims, but it should also not be used to dismiss legitimate clinical patterns.

Related HormoneSynergy® Resources

• HormoneSynergy® Longevity Medicine Resource Library
• Bioidentical Hormone Replacement Therapy at HormoneSynergy®
• Optimal Aging Assessment

References

• Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. 2019.
• Androgen Therapy in Women: A Reappraisal. Endocrine Society Clinical Practice Guideline. 2014.
• Testosterone Therapy in Men with Androgen Deficiency Syndromes. Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2010.
• Sarcopenia and Menopause: The Role of Estradiol. Frontiers in Endocrinology. 2021.
• How the Loss of Estrogen Impacts Muscle Strength. Experimental Gerontology. 2019.
• Sarcopenia in Menopausal Women: Current Perspectives. International Journal of Women’s Health. 2022.
• The Effect of Resistance Training Programs on Lean Body Mass in Postmenopausal and Elderly Women. Aging Clinical and Experimental Research. 2021.
• The Effects of Testosterone Administration on Muscle Areas in Women with Low Testosterone Levels. Journal of Clinical Endocrinology & Metabolism. 2019.

Editorial Transparency

This article is educational and is not personal medical advice. Testosterone therapy in women should be individualized, monitored carefully, and interpreted in context.

HormoneSynergy® does not use testosterone as a wellness trend, bodybuilding intervention, or substitute for exercise, nutrition, sleep, and metabolic health. Our clinical approach is to evaluate the full picture: symptoms, hormone history, surgical history, body composition, strength, cardiometabolic risk, inflammation, medications, and patient goals.